Skip to main content

Table 3 Disease severity and neuropsychological assessment in PD patients with different PWMH gradings

From: Systemic oxidative stress and cognitive function in Parkinson’s disease with different PWMH or DWMH lesions

PWMH gradings

Normal (n=16)

Mild (n=90)

moderate to severe (n=40)

P

P1

P2

P3

Gender (male, female)

9,7

37,53

19, 21

0.523

0.285

0.442

0.704

Age (years, mean (SD))

57.81 (11.49)

62.58 (10.67)

69.50 (8.60)

0.001*

0.067

0.001*

0.001*

HTN (number, percentage)

4 (25%)

31 (34.4%)

19 (47.5%)

0.211

0.461

0.125

0.160

DM (number, percentage)

2 (12.5%)

11 (12.2%)

6 (15%)

0.909

0.975

0.811

0.666

Hypercholesterolemia (number, percentage)

2 (12.5%)

20 (22.2%)

9 (22.5%)

0.665

0.379

0.399

0.972

Smoking (number, percentage)

0

4 (4.4%)

0

0.281

0.392

1.000

0.177

Medications (number, percentage)

11 (68.8%)

28 (31.1%)

13 (32.5%)

0.014*

0.004*

0.014*

0.875

UPDRS total, mean (SD)

43.43 (22.11)

36.68 (23.50)

41.58 (29.09)

0.456

0.229

0.486

0.555

Modified Hoehn and Yahr scale, mean (SD)

2.18 (1.34)

1.86 (1.04)

2.03 (1.26)

0.761

0.445

0.669

0.803

Schwab and England ADL scale, mean (SD)

82.67 (13.87)

83.97 (16.30)

80.52 (22.29)

0.823

0.527

0.680

0.841

MMSE, mean (SD)

27.62 (2.24)

24.71 (4.54)

22.56 (5.73)

0.001*

0.007*

0.001*

0.033*

Neuropsychological battery

 Attention, mean (SD)

0.83 (1.16)

−0.46 (2.17)

−1.44 (2.80)

0.003*

0.030*

0.001*

0.034*

 Executive function, mean (SD)

0.71 (3.97)

−0.97 (4.23)

−2.23 (5.11)

0.113

0.130

0.060

0.225

 Memory, mean (SD)

0.78 (1.14)

−0.36 (2.06)

−1.54 (2.94)

0.003*

0.033*

0.001*

0.037*

 Language, mean (SD)

0.31 (2.12)

−0.36 (2.20)

−1.48 (3.00)

0.040*

0.380

0.044*

0.028*

 Visual-spatial, mean (SD)

0.18 (1.96)

−0.83 (2.10)

−1.35 (2.57)

0.058

0.065

0.029*

0.210

  1. Kruskal-Wallis H test was used for between-group comparisons of three groups, and Mann-Whitney U test was used for between-two-group comparisons
  2. P Comparison of group 0, 1 and 2+ 3, P1 Comparison of group 0 and 1, P2 Comparison of group 0 and 2+ 3, P3 Comparison of group 1 and 2+ 3, SD Standard deviation, PD Parkinson’s disease, PWMH Periventricular white matter hyperintensities, HTN Hypertension, DM Diabetes Mellitus; Medications, was defined as Benzodiazepines
  3. *p< 0.05